| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 3 |
| 1 | CAPECITABINE | 3 |
| 2 | OXALIPLATIN | 3 |
| 3 | CHLOROTHIAZIDE | 1 |
| 4 | CHLOROTHIAZIDE SODIUM | 1 |
| 5 | CLOPIDOGREL | 1 |
| 6 | CLOPIDOGREL BISULFATE | 1 |
| 7 | ERYTHROMYCIN ETHYLSUCCINATE | 1 |
| 8 | FAMOTIDINE | 1 |
| 9 | FUROSEMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERYTHROMYCIN ETHYLSUCCINATE | 1 | 0.0016 |
| 1 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | VOCLOSPORIN | 1 | 0.0001 |
| 4 | NOREPINEPHRINE BITARTRATE | 1 | 0.0001 |
| 5 | OXALIPLATIN | 3 | 0.0000 |
| 6 | CAPECITABINE | 3 | 0.0000 |
| 7 | SILDENAFIL POWDER, | 1 | 0.0000 |
| 8 | BEVACIZUMAB | 3 | 0.0000 |
| 9 | UPADACITINIB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 1 | Catecholamine [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |